Pyridine → HCID 57906441, compound
Reaction equation
C(OC(=O)[NH:7][CH2:8][C:9]1[C:14]([C:15]2[CH:20]=[CH:19][C:18]([Cl:21])=[CH:17][C:16]=2[Cl:22])=[CH:13][N:12]2[C:23]([N:26]3[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]3)=[CH:24][N:25]=[C:11]2[CH:10]=1)(C)(C)C.[C:33](Cl)(=[O:35])[CH3:34].N1C=CC=CC=1>C(Cl)Cl.CN(C1C=CN=CC=1)C>[NH2:7][CH2:8][C:9]1[C:14]([C:15]2[CH:20]=[CH:19][C:18]([Cl:21])=[CH:17][C:16]=2[Cl:22])=[CH:13][N:12]2[C:23]([N:26]3[CH2:27][CH2:28][N:29]([C:33](=[O:35])[CH3:34])[CH2:30][CH2:31]3)=[CH:24][N:25]=[C:11]2[CH:10]=1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of [6-(2,4-dichloro-phenyl)-3-piperazin-1-yl-imidazo[1,2-a]pyridin-7-ylmethyl]-carbamic acid tert-butyl ester (30 mg, 0.06 mmol) in DCM (0.5 mL) were added successively acetyl chloride (6 mg, 0.07 mmol), pyridine (0.015 mL, 0.19 mmol) and DMAP (1 mg, 0.006 mmol). The reaction mixture was stirred at RT for 14 h then evaporated to dryness. The resulting residue was dissolved in DCM (2 mL) then TFA (1 mL) was added and the mixture was stirred at RT for 30 min. The reaction mixture was concentrated to dryness and the remaining residue purified by reverse phase prep-HPLC (Waters system) to give the title compound (2TFA salt, 22 mg, 0.034 mmol, 57% for 2 steps) as a white solid. MS: 419 [M+1]+; HPLC: AtRet=1.00.
Workup
- customthen evaporated to dryness
- dissolutionThe resulting residue was dissolved in DCM (2 mL)
- additionTFA (1 mL) was added
- stirringthe mixture was stirred at RT for 30 min
- concentrationThe reaction mixture was concentrated to dryness
- customthe remaining residue purified by reverse phase prep-HPLC (Waters system)
Sources & evidence
- ORD record
- ord-adf1d230de9c4359ad61a4c876ed2ebe
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08097617B2
Reaction notes
Loading…